Daniel Fults III, MD, is a member of Huntsman Cancer Institute’s Brain Tumor program and a professor of neurosurgery at the University of Utah School of Medicine. He is also a member of the Cell Response and Regulation Program. His clinical practice focuses on the surgical treatment of patients with brain tumors.

Fults’ laboratory research centers on the development of medulloblastoma, a malignant brain tumor that afflicts children. His research group studies how defects in signaling molecules that normally govern the growth and differentiation of neural progenitor cells cause medulloblastoma. Neural progenitor cells are the parent cells that give rise to brain and nerve cells.

Fults received a BS in chemistry from the University of Texas at Austin and earned his MD at the University of Texas Southwestern Medical School in Dallas. He served internship and residency in neurological surgery at Wake Forest University School of Medicine in Winston-Salem, North Carolina. He was a postdoctoral fellow in molecular biology in the Departments of Surgery and Biochemistry at the University of North Carolina School of Medicine in Chapel Hill. Fults is accredited with the American Board of Neurological Surgery. He joined Huntsman Cancer Institute in May 1999.